AUG 01, 2019 10:14 AM PDT

Novel Therapy Shows Promise for Acute Migraines

WRITTEN BY: Nouran Amin

In a study published in The New England Journal of Medicine, a novel drug, by the name of rimegepant, was found to eliminate pain and reduce characteristic symptoms of an acute migraine in comparison to over-the counter drugs. The study was carried out by Albert Einstein College of Medicine and Montefiore Health System for a large clinical trial and is now awaiting the approval of rimegepant by the U.S. Food and Drug Administration. "For the first time in nearly three decades, people with migraine not helped by existing medications may have a new option to find relief during attacks," says first author, Richard B. Lipton, M.D.

Migraines are debilitating and currently affect about 12 to 14% of people worldwide. It is neurologic disorder characterized by periodic attacks of head pain along with symptoms ranging from feelings of nausea to sensitivity from light and sound. Most sufferers experience at least one migraine attack per month with more than half left severely impaired during their attacks.

Presently, individuals with migraines likely take triptan medications that work to reduce inflammation and constrict blood vessels. These drugs are not beneficial to everyone and can cause intolerable side effect. However, with the novel drug rimegepant, it opens the door for effective and tolerable treatment options besides triptan. "These results confirm that rimegepant's mechanism of action -- blocking the CGRP pathway -- effectively relieves pain and associated symptoms that occur during acute migraine attacks," said Dr. Lipton. "As someone who has studied CGRP blockers for more than a decade, I'm gratified to see their benefits confirmed in a large-scale clinical trial."

Source: Albert Einstein College of Medicine

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAY 15, 2021
Drug Discovery & Development
New Drug Blocks Critical Step in Malaria Life Cycle
MAY 15, 2021
New Drug Blocks Critical Step in Malaria Life Cycle
According to the World Health Organization (WHO), in 2019, there were approximately 229 million cases of malaria around ...
JUN 03, 2021
Drug Discovery & Development
Smartphone App More Effective than Traditional Treatment for Osteoarthritis
JUN 03, 2021
Smartphone App More Effective than Traditional Treatment for Osteoarthritis
  Researchers at the University of Nottingham in the UK and Joint Academy have found that a clinical evidence-based ...
JUN 04, 2021
Drug Discovery & Development
Stem Cell Transplants May Treat Patients with Type 2 Diabetes
JUN 04, 2021
Stem Cell Transplants May Treat Patients with Type 2 Diabetes
Researchers at the Vinmec Research Institute of Stem Cell and Gene Technology in Hanoi, Vietnam have found that stem cel ...
JUN 28, 2021
Drug Discovery & Development
Could Deep Brain Stimulation Treat Schizophrenia?
JUN 28, 2021
Could Deep Brain Stimulation Treat Schizophrenia?
From a new case study, researchers from Johns Hopkins University have found that deep brain stimulation may be able to i ...
JUN 29, 2021
Microbiology
Gut Fungi May Be an Untapped Reservoir of Antibiotics
JUN 29, 2021
Gut Fungi May Be an Untapped Reservoir of Antibiotics
Viruses are not the only microbes that can cause serious public health problems. Researchers have been warning about a p ...
JUL 27, 2021
Immunology
Rethinking Immune Responses Involved in Skin Hypersensitivity
JUL 27, 2021
Rethinking Immune Responses Involved in Skin Hypersensitivity
A study by immunologists at the University of Copenhagen has revealed a never-before-seen immune pathway invol ...
Loading Comments...